Please login to the form below

Not currently logged in
Email:
Password:

MorphoSys strengthens senior clinical development team

Appoints Gabriele Elbl, Ludger Langer and Steffen Heeger

Morphosys Dr Gabriele ElblGerman biotech company MorphoSys has expanded its senior clinical development team with three new management appointments.

Regulatory affairs head Dr Gabriele Elbl (pictured right) joins MorphoSys from Munich-based biopharmaceutical company Wilex AG, where she was senior vice president of regulatory affairs.

Prior to that she worked as a scientific administrator at the EMA, London, and served as head of pharmaceutical department at Sanofi Winthrop in Munich.

Dr Ludger Langer moves to MorphoSys from contract research organisation PRA International to take up the position of head of clinical operations and project management.

He brings almost 20 years of clinical operations and project management experience to MorphoSys prior to which he was vice president, clinical operations, Europe, Asia-Pacific and Africa at PRA.

Finally MorphoSys has also appointed Dr Steffen Heeger as head of clinical research. He was previously head of medical affairs at Merck Serono, where he also led the global clinical development team for its cancer drug Erbitux.

6th January 2014

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...